Stephen Zou

Dr. Zou focuses mainly on intellectual property strategic consulting, patent portfolio management, patent infringement, validity, and freedom-to-operate opinions, due diligence, and dispute resolution; representing many multinational pharmaceutical companies, small and medium-sized innovative companies in handling intellectual property, drug regulatory matters and market admission related legal affairs.

The wide variety of technical areas in which Dr. Zou has obtained and enforced patent protection for clients include pharmacy, chemistry, and biotechnologies, as well as mechanical systems and medical devices.

All-China Patent Agents Association (ACPAA)

All China Lawyers Association (ACLA)

Association Internationale pour la Protection de la Propriété Intellectuelle (AIPPI)

- Claim definitions Undergoing Change, China IP Focus 2014, Managing Intellectual Property, 2014 [Co-authored]

- How to determine novelty-conferring features for a medical use claim, China IP Focus 2015, Managing Intellectual Property, 2015 [Co-authored]

- Disclosure requirements undergoing change, IAM Life Science (2015) [Co-authored]

- How to make sure your patent is properly supported in China, March 2016 [Co-author]

- Implications of recent life sciences cases in China, IAM Life Science March 2017 [Co-authored]

- Overview of regulatory reform in China, IAM Life Sciences, 2018. [Co-authored]

- Patent practice: recent developments in life sciences in China, IAM Life Sciences 2019, pp. 51-55 [Co-authored]

- Doctrine of equivalents for life science patents in China, IAM Life Sciences 2020, pp. 53-57 [Co-authored]